Dr. Peter Stacpoole, PhD, MD
Claim this profileStudies Glioblastoma
1 reported clinical trial
1 drug studied
Clinical Trials Peter Stacpoole, PhD, MD is currently running
More about Peter Stacpoole, PhD, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Peter Stacpoole, PhD, MD has experience with
- Dichloroacetate (DCA)
Breakdown of trials Peter Stacpoole, PhD, MD has run
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Stacpoole, PhD, MD specialize in?
Peter Stacpoole, PhD, MD focuses on Glioblastoma and other conditions. In particular, much of their work with Glioblastoma has involved treating patients, or patients who are undergoing treatment.
Is Peter Stacpoole, PhD, MD currently recruiting for clinical trials?
Yes, Peter Stacpoole, PhD, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Peter Stacpoole, PhD, MD has studied deeply?
Yes, Peter Stacpoole, PhD, MD has studied treatments such as Dichloroacetate (DCA).
What is the best way to schedule an appointment with Peter Stacpoole, PhD, MD?
Apply for one of the trials that Peter Stacpoole, PhD, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.